Current evidence from large human studies does not support the idea that undergoing general anesthesia causes Parkinson’s disease. A nested case-control study found no significant link between anesthetic exposure and the development of alpha-synuclein disorders, even when researchers looked at people who had been put under multiple times or for long cumulative durations. That said, the question is more layered than a flat “no” suggests, because laboratory research has identified several ways anesthetic drugs can stress the very brain cells that Parkinson’s destroys, and a few older studies raised concerns about chronic occupational exposure among anesthesiologists themselves.
What Large Population Studies Show
The strongest evidence on this question comes from studies that track large numbers of people over years and compare Parkinson’s rates between those who had surgery under general anesthesia and those who did not. A study using a matched cohort of patients who underwent appendectomy under general anesthesia found no increased risk of subsequent Parkinson’s disease. The rate of Parkinson’s in the surgery group was actually slightly lower than in the matched controls, but the researchers cautioned against interpreting that as a protective effect. Their conclusion was straightforward: general anesthesia for surgery did not raise the risk of developing Parkinson’s afterward.1British Journal of Anaesthesia. Risk of Parkinson’s disease after anaesthesia and surgery
A separate study took a different angle by looking specifically at alpha-synucleinopathies, the family of diseases that includes Parkinson’s. It examined whether anesthetic exposure, measured both as a simple yes-or-no and by number of exposures and total hours under anesthesia, predicted who developed these disorders. None of the measures showed a significant association. Even people who had been anesthetized four or more times showed no elevated risk compared to those who had never been put under.2PubMed Central. Exposure to anesthesia is not associated with development of α-synucleinopathies: A nested case-control study
These findings are reassuring for the millions of people who undergo surgery each year, but they do not mean the question is entirely settled. Both studies have the limitation shared by all observational research: they can identify associations but cannot prove causation in either direction. And the follow-up periods, while measured in years, may not capture effects that take decades to manifest.
The Reverse Causation Problem
One of the trickiest aspects of studying any environmental trigger for Parkinson’s is the disease’s long prodromal phase. Before the classic tremor and stiffness appear, Parkinson’s can quietly produce symptoms like constipation, sleep disturbances, depression, and chronic pain for ten to twenty years. People experiencing these symptoms are more likely to end up in a hospital for various procedures, which means they are more likely to receive anesthesia, not because anesthesia is causing their eventual Parkinson’s but because their early Parkinson’s is sending them to surgeons. This phenomenon, called reverse causation, is a major concern for researchers trying to untangle the relationship between anesthesia exposure and later Parkinson’s diagnosis.3PubMed. Prodromal symptoms of Parkinson’s disease: Implications for epidemiological studies of disease etiology
If a study finds that people diagnosed with Parkinson’s had more surgeries in the decade before diagnosis, the naive interpretation is that the surgeries (or the anesthesia) contributed. The more likely explanation is that the disease was already brewing and driving them toward medical care. Well-designed studies try to account for this by imposing a lag period, only counting anesthesia exposures that happened many years before diagnosis, or by matching patients carefully on other health factors. Still, it is extremely difficult to fully eliminate this bias, and it hangs over nearly every observational finding in this area.
What Lab Research Says About Anesthetics and Brain Cells
While large human studies have been reassuring, laboratory work tells a more complicated story. Researchers have identified several ways that anesthetic agents can stress the types of brain cells that degenerate in Parkinson’s disease. These findings come mostly from animal experiments and cell cultures, and they do not automatically translate to what happens in a living person during a routine surgery. But they explain why the question keeps getting asked.
Parkinson’s disease is driven by the loss of dopamine-producing neurons in a brain region called the substantia nigra. In rat studies, the degree of dopamine neuron loss after exposure to a neurotoxin varied dramatically depending on which anesthetic was used during the experiment. Animals under isoflurane (a common inhaled anesthetic) lost far more dopamine neurons than those under ketamine-based anesthesia when exposed to the same toxin dose. This does not mean isoflurane itself killed the neurons, but it suggests different anesthetics may leave these cells more or less vulnerable to simultaneous stressors.4PubMed. Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats
Separately, studies of brain tissue slices have shown that common inhaled anesthetics like halothane and isoflurane alter dopamine release patterns in the striatum, the brain region that receives dopamine signals from the substantia nigra. These agents boosted spontaneous dopamine release while reducing dopamine release triggered by stimulation.5Anesthesiology. Halothane and Isoflurane Increase Spontaneous but Reduce the N-methyl-D-aspartate–evoked Dopamine Release in Rat Striatal Slices Whether this disruption has any lasting consequences in humans exposed to these drugs for a few hours during surgery is unknown, but it demonstrates that anesthetics are not inert when it comes to the dopamine system.
Alpha-Synuclein, Mitochondria, and the Cellular Stress Story
Beyond dopamine release, researchers have investigated whether anesthetics can trigger the kind of protein clumping that is a hallmark of Parkinson’s. Alpha-synuclein is a protein that, when it misfolds and aggregates into clumps, becomes toxic to neurons and is considered central to Parkinson’s pathology. A study in aged rats found that prolonged propofol anesthesia, both alone and during surgery, suppressed a cellular cleanup process called autophagy in the hippocampus. With that cleanup process dampened, alpha-synuclein aggregates accumulated alongside imbalances in brain chemicals, and the rats showed measurable cognitive deficits.6PubMed Central. Autophagy prevents hippocampal α-synuclein oligomerization and early cognitive dysfunction after anesthesia/surgery in aged rats
There is also a growing body of work on mitochondrial damage. Mitochondria, the energy-producing structures inside cells, are already implicated in Parkinson’s. Experimental evidence shows that general anesthetics can damage mitochondria through several routes: generating harmful reactive oxygen species, disrupting the chain of chemical reactions that produces cellular energy, and triggering a process that causes mitochondria to leak and eventually self-destruct.7PubMed. Molecular pathways of mitochondrial dysfunctions: possible cause of cell death in anesthesia-induced developmental neurotoxicity In young mice, several common anesthetics caused measurable drops in mitochondrial energy output, and blocking a key step in this damage pathway prevented the cognitive problems that otherwise followed.8Frontiers in Neurology. The effects of general anesthetics on mitochondrial structure and function in the developing brain
The critical caveat here is scale. Most of these studies use anesthetic exposures that are longer, higher in concentration, or applied to animals at vulnerable developmental stages. A healthy adult receiving two hours of anesthesia for a knee replacement is in a very different situation from a neonatal mouse immersed in isoflurane for hours. The lab findings identify a mechanism that could theoretically matter, but they do not establish that it does matter in clinical practice.
The Blood-Brain Barrier and Neuroinflammation
Surgery itself, quite apart from the anesthetic drugs used, creates a systemic inflammatory response. Your body treats the incision, tissue manipulation, and healing process as an injury and mounts an immune response accordingly. Research in aged mice has shown that this surgery-triggered inflammation can activate an enzyme that damages the blood-brain barrier, the tightly sealed lining that normally keeps inflammatory molecules in the bloodstream from entering the brain. Once that barrier is compromised, peripheral inflammation spills into the central nervous system, causing neuroinflammation and disrupting the connections between neurons.9PubMed. Anesthesia/surgery activate MMP9 leading to blood-brain barrier disruption, triggering neuroinflammation and POD-like behavior in aged mice
This is an important nuance in the debate. Many studies that look at “anesthesia and Parkinson’s” are really studying “anesthesia plus surgery” as a package. Separating the effects of the drugs from the effects of the surgical trauma is difficult because, outside of research settings, the two almost always happen together. It remains unclear whether anesthesia alone, without any surgical insult, would produce the same neuroinflammatory cascade. The fact that the largest population studies found no increased Parkinson’s risk from surgery under general anesthesia suggests that even if neuroinflammation occurs transiently, it does not typically snowball into a neurodegenerative disease.
Occupational Exposure Is a Different Question
A separate strand of research has looked not at patients receiving anesthesia but at healthcare workers who are chronically exposed to anesthetic gases in the operating room. A case report and review cited a case-control study reporting roughly double the risk of Parkinson’s in people with a history of general anesthesia exposure and a cohort study comparing death rates from Parkinson’s between U.S. anesthesiologists and internists, finding a statistically significant excess among anesthesiologists.10PubMed Central. Exposure to anesthetic gases and Parkinson’s disease: a case report
This is a genuinely different scenario from a patient being put under once or twice in a lifetime. Anesthesiologists and nurse anesthetists can be exposed to trace amounts of waste anesthetic gases for thousands of hours over a career, even with modern scavenging systems that capture most of the exhaled agents. Whether this low-level, chronic exposure carries a meaningful risk is still not clear. The studies cited are relatively small, and they have not been replicated in ways that fully control for other occupational exposures and lifestyle factors. But the data are enough to keep the question alive among occupational health researchers, and they explain why operating room ventilation standards exist.
The Glymphatic System Wrinkle
A more recently discovered piece of the puzzle involves the brain’s waste-clearance system. The glymphatic system is a network that flushes metabolic waste, including misfolded proteins like alpha-synuclein, out of brain tissue during certain states of consciousness. There was an early assumption that anesthesia, like natural sleep, would enhance this flushing. Research using multiple imaging methods and different anesthetic drugs showed the opposite: general anesthesia significantly impaired glymphatic activity, especially at higher doses. The brain’s ability to clear waste was substantially reduced under anesthesia compared to normal wakefulness.11PubMed Central. General Anesthesia Inhibits the Activity of the “Glymphatic System”
This finding has implications for the protein-aggregation question. If anesthesia temporarily shuts down the system that clears misfolded proteins from the brain, and if anesthesia also promotes the formation of those misfolded proteins (as the alpha-synuclein study in aged rats suggested), you have a scenario where production goes up and removal goes down at the same time. Whether this temporary double hit during a few hours of surgery has lasting consequences in an otherwise healthy brain is speculative. But in someone whose waste-clearance or protein-folding systems are already compromised, perhaps due to aging or genetic susceptibility, the concern becomes more plausible.
Who Might Be More Vulnerable
Parkinson’s disease is understood to result from a combination of genetic predisposition and environmental exposures accumulated over a lifetime. After aging, a family history of Parkinson’s is the strongest predictor of developing the disease. Most evidence supports a genetic component, though it likely involves genes with low penetrance, meaning you can carry a risk gene and never develop Parkinson’s.12British Journal of Anaesthesia. Anaesthesia and Parkinson’s disease
This matters for the anesthesia question because the laboratory findings about mitochondrial damage, alpha-synuclein clumping, and glymphatic impairment may be more relevant in people who already carry genetic vulnerabilities. A brain that is efficiently clearing waste, producing healthy mitochondria, and properly folding its proteins is presumably better equipped to absorb a temporary insult from anesthesia than one that is already struggling on those fronts. No study has yet directly tested whether people with known Parkinson’s risk genes experience worse outcomes from anesthesia specifically in terms of later neurodegeneration, but the biological reasoning makes it a reasonable question for future research.
Age is another factor. Most of the laboratory studies that find worrying effects use either very young or very old animals, suggesting that vulnerability to anesthetic-related brain stress varies over the lifespan. The aged rat study that found alpha-synuclein aggregation after propofol used old animals specifically because the researchers suspected aging would lower the threshold for damage. For a healthy thirty-year-old having a routine surgery, the risk profile is almost certainly different from that of an eighty-year-old with multiple health conditions undergoing a long operation.
Practical Concerns for People Who Already Have Parkinson’s
While anesthesia does not appear to cause Parkinson’s disease, undergoing anesthesia when you already have Parkinson’s creates a distinct set of challenges. People with Parkinson’s are at higher risk for complications during and after surgery. A study comparing postoperative delirium rates found that patients with Parkinson’s had roughly twice the odds of developing delirium after common surgical procedures compared to matched patients without Parkinson’s.13PubMed. Association of Postoperative Delirium and Parkinson Disease After Common United States Surgical Procedures
One of the biggest perioperative concerns is managing Parkinson’s medications. Dopaminergic drugs need to be taken on a strict schedule, and missing even one dose can cause a dramatic worsening of motor symptoms. The fasting period before surgery makes oral medication tricky, and many hospital staff are unfamiliar with the urgency of keeping these medications on time. Non-oral alternatives, such as a skin patch or inhaled formulations, can bridge the gap when a patient cannot swallow pills.14PubMed. A Pragmatic Approach to the Perioperative Management of Parkinson’s Disease
The choice of anesthetic technique also matters for patients with existing Parkinson’s. A small comparison of patients with Parkinson’s who received general versus spinal anesthesia found that those who had spinal anesthesia experienced fewer complications and shorter hospital stays. The general anesthesia group averaged nine days in the hospital compared to about six days for the spinal anesthesia group, and three out of four patients in the general anesthesia group developed postoperative complications versus just one in the spinal group.15PubMed Central. Spinal versus General Anesthesia for Patients with Parkinson’s Disease This was a small study, so the numbers should be interpreted cautiously, but the general principle that regional anesthesia may carry advantages for Parkinson’s patients is consistent with broader guidance favoring less invasive approaches in neurologically vulnerable patients.16PubMed. Peri-operative management of patients with Parkinson’s disease
Preconditioning and the Possibility of Protection
In a curious twist, some research has explored whether low-level anesthetic exposure might actually protect against neurotoxin-induced brain damage under certain conditions. The concept, borrowed from cardiac research, is that a mild stress can prime cells to survive a larger stress later. In mice, preconditioning with a low-level stressor reduced the damage caused by MPTP, a neurotoxin that produces Parkinson’s-like degeneration in animals. Gas anesthetics were identified as one potential preconditioning stimulus, and the protective effect appeared to involve proteins that help cells survive oxidative stress.17PubMed. Roles of thioredoxin in nitric oxide-dependent preconditioning-induced tolerance against MPTP neurotoxin
This line of research is in its infancy and should not be taken as a reason to seek out anesthesia. But it illustrates why the relationship between anesthetics and the brain is not a simple story of harm. The same drugs that can disrupt dopamine signaling and impair waste clearance in one context may trigger protective cellular responses in another. Biology is rarely one-directional, and the net effect of anesthesia on neurodegeneration likely depends on factors like dose, duration, the patient’s age, their genetic makeup, and whether surgery is happening at the same time. For now, the population-level data offer the most practical guidance: getting anesthesia for a needed surgery does not appear to put you on a path toward Parkinson’s disease.